Carisma Therapeutics Inc. held a Special Meeting of Stockholders on August 5, 2025. During the meeting, stockholders approved an amendment to the Restated Certificate of Incorporation to effect a reverse stock split of the company's issued shares of common stock at a ratio within the range of 1-for-10 to 1-for-50. The exact ratio and timing will be determined by the Board of Directors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carisma Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-075680), on August 08, 2025, and is solely responsible for the information contained therein.